✦ LIBER ✦

Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer

✍ Scribed by Rao, S; Cunningham, D; Price, T; Hill, M E; Ross, P J; Tebbutt, N; Norman, A R; Oates, J; Shellito, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Chronomodulated administration of oxalip

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of capecitabine plus oxal

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Reply: Capecitabine and bevacizumab as f

✍ Feliu, J; Barriuso, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Comment on ‘Capecitabine and bevacizumab

✍ Molina-Garrido, M J; Guillén-Ponce, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB